- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: professional level
- Also shares: hybrid delivery
Back to StakeholdersPrimary Service Link Visit Provider Exeter University Geneva University Hospital HoloMind COMPASS Pathways
Categories
3 domains / 7 areas / 7 specializations
Clerkenwell Health
Data updated
Central London clinic (city-level coordinate), United KingdomDoncaster clinic (city-level coordinate), United Kingdom
1 Trial
UK psychedelic and CNS trial infrastructure provider with specialist trial sites, sponsor-facing psychiatric research support, recruitment pathways, and therapist-related trial expertise.
ProfessionalHybridMid costPsychedelic-assisted therapy trainingContinuing educationAcademic programmeLicensed cliniciansAspiring practitionersResearchersFacilitators
Blossom’s read
Clerkenwell Health looks like a serious UK clinical-research outfit rather than a glossy wellness school: their training sits inside a broader CNS and psychedelic trial delivery business, with a clear emphasis on therapist capacity for research settings. The strongest fit is healthcare professionals and experienced therapists who want to work on psychedelic clinical trials or build adjacent competence, not people looking for a casual public-facing introduction. Its lineage is fairly pragmatic and trial-led, with visible input from former Compass Pathways figures and an evidence-based, regulator-conscious tone.
Who Clerkenwell Health is for
Best for healthcare professionals, qualified therapists and clinicians who want psychedelic-assist therapy skills in a research or trial context. It is less suited to the curious public or anyone seeking a stand-alone consumer certificate for private practice.
Prerequisites
The Foundations Programme is for healthcare professionals. The Certificate Programme is for qualified therapists, counsellors, psychologists, and medical doctors with training in psychological therapies, and applicants must demonstrate a minimum standard of competency in a mock interview assessed using the Facilitative Interpersonal Skills framework.
Accreditation & recognition
Clerkenwell says the training is aligned with standards from accreditation bodies and that CPD points are available for those who complete the training. The site also says they are working with bodies to think through an accreditation pathway, but I did not find evidence of an externally awarded professional accreditation or formal licence to practise.
Cost
The current programme page lists a Foundations Programme at £500 and a Certificate Programme at £2,000, payable in instalments. Clerkenwell also says a limited number of reduced-cost places are available for participants from lower-income households; an older blog post described an earlier therapist training programme as free, so pricing appears to have changed over time.
What you walk away with
Learners gain practical training and mentoring in psychedelic-assisted therapy, with the Foundations and Certificate routes intended to build knowledge and clinical skills. Clerkenwell says successful participants are well placed to apply for therapist roles on psychedelic research trials, and the training is framed as preparing practitioners to work to consistent core competencies.
Clinical Trial Infrastructure Snapshot
Specialized Trial ServicesService Model
Hybrid
Service Coverage
1 country
Psychedelic Experience
Verified Psychedelic Trial Experience
Last Source Check
Jun 18, 2026
Public Sources
4
Lifecycle Coverage
Feasibility & Protocol DesignStudy Startup & Site ActivationRecruitment & RetentionTrial Operations & MonitoringData Management & BiostatisticsSafety Operations / Pharmacovigilance
Service Coverage Countries
United Kingdom
Phase Coverage
Phase IPhase IIPhase III
Capabilities
Site Network AccessPatient Recruitment MediaBiometrics / Statistics
Research Update
Public-source profile available
Last checked Jun 18, 2026 across 4 sources.
Search Finding
Built specifically for CNS and psychedelic research; Europe's first commercial site dedicated to psychedelic trials; UK trial-site network and therapist-facing trial expertise.
Service Notes
Profile should emphasize the current verified UK sites and sponsor/CRO support. Future five-site ambitions should stay contextual until verified as live coverage.
Linked Stakeholders
No linked stakeholders yet.
Linked Trials
An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
Completed
A Phase 3 Trial to Assess CYB003 in Major Depressive Disorder (EMBRACE)
Recruiting
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Active not recruiting
BPL-003 Efficacy and Safety in Treatment Resistant Depression
Completed
A dose-finding and proof-of-concept study of the efficacy and safety of MSP-1014.OX in patients with major depressive disorder
Completed
Phase 2 Clinical Trial of GH001 in Postpartum Depression
Terminated
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD (COMP 006)
Active not recruiting
Clinical Care Delivery Snapshot
Specialty & Outpatient ClinicsProvider Model
Independent Specialty Clinic
Organization Status
Unknown
Psychedelic Services
Unknown
Service Coverage
Global
Service Profile
Care Settings
Specialty Outpatient Clinic
Payer Models
Unknown
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Backfilled profile for existing L2 clinical care delivery stakeholder.
Similar course providers
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.
- Strong match: 2 shared modalities
- Strong match: 2 shared learner audiences
- Also shares: professional level
- Also shares: hybrid delivery
- Strong match: 3 shared modalities
- Strong match: 4 shared learner audiences
- Also shares: professional level
- Also shares: hybrid delivery
- Strong match: 3 shared modalities
- Strong match: 2 shared learner audiences
- Also shares: professional level
- Also shares: hybrid delivery
Quick Facts
- Type
- Other
- Founded
- 2020
- HQ
- Central London clinic (city-level coordinate), United Kingdom
- Website
- Visit